Completion of Enrollment Positions CELZ for Near-Term Data Catalysts and Accelerates Path Toward Commercialization of a Transformative, Non-Opioid Therapy…
PHOENIX, Dec. 17, 2025 (GLOBE NEWSWIRE) — Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ), a clinical-stage biotechnology company advancing regenerative medicine solutions, today announced the successful completion of patient enrollment in… [5296 chars]
Source: GlobeNewswire | Published: 2025-12-17T14:15:00Z
Credit: GlobeNewswire
